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In Brief
Down syndrome (DS) patients invariably
develop Alzheimer’s disease (AD) pathol-
ogy in their 40s. It has been reported that
SNX27 deficiency contributes to impaired
learning and memory in DS. In this study,
Wang et al. show that SNX27 regulates
APP cleavage and Ab generation. In addi-
tion, they suggest that SNX27 acts as a g-
secretase interaction partner and show
that the interaction dissociates the g-sec-
retase complex, thus decreasing its pro-
teolytic activity. The results provide a
new clue to the pathogenesis of DS and
AD.
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Patients with Down syndrome (DS) invariably
develop Alzheimer’s disease (AD) pathology in their
40s. We have recently found that overexpression of
a chromosome 21-encoded microRNA-155 results
in decreased levels of the membrane trafficking
component, SNX27, diminishing glutamate receptor
recycling and thereby impairing synaptic functions
in DS. Here, we report a function of SNX27 in regu-
lating b-amyloid (Ab) generation by modulating
g-secretase activity. Downregulation of SNX27 using
RNAi increased Ab production, whereas overexpres-
sion of full-length SNX27, but not SNX27DPDZ,
reversed the RNAi-mediated Ab elevation. Moreover,
genetic deletion of Snx27 promoted Ab production
and neuronal loss, whereas overexpression of
SNX27 using an adeno-associated viral (AAV) vector
reduced hippocampal Ab levels in a transgenic
AD mouse model. SNX27 associates with the g-sec-
retase complex subunit presenilin 1; this interac-
tion dissociates the g-secretase complex, thus
decreasing its proteolytic activity. Our study estab-
lishes a molecular mechanism for Ab-dependent
pathogenesis in both DS and AD.INTRODUCTION
Down syndrome (DS), or trisomy 21, is a congenital disorder
manifesting defects in multiple organs and causing develop-
mental delay and learning disabilities. DS patients have an extra
copy of chromosome 21, leading to an overdosage of gene prod-
ucts and noncoding RNAs encoded by this chromosome,
including the b-amyloid precursor protein (APP). APP can be
proteolytically cleaved by b-secretase (BACE1) and presenilin
1 (PS1)/g-secretase to generate neurotoxic b-amyloid (Ab) pep-
tides. Overproduction/accumulation of Ab in the brain contrib-Cell Rutes to DS pathogenesis and is a causative factor in Alzheimer’s
disease (AD) pathogenesis. Virtually all DS patients develop AD-
like neuropathology by the age of 40, including extracellular
neuritic/amyloid plaques comprising Ab peptides of varying
sizes, intracellular neurofibrillary tangles, synaptic dysfunction,
and neurodegeneration in vulnerable brain regions. While the ex-
tra copy of APP on chromosome 21 is thought to contribute to
the AD-like pathology in DS patients, the detailed molecular
mechanisms by which trisomy 21 results in AD-like neuropa-
thology remain largely unclear. The majority of early-onset famil-
ial AD cases are associatedwithmutations inPS1,PS2, andAPP
genes, all of which result in Ab overproduction (Bertram et al.,
2010; Shen, 2014). Multiple lines of evidence suggest that over-
production/aggregation of Ab in the brain is the primary cause of
AD pathogenesis. Current Ab-directed therapeutic strategies
mainly target b-secretase (BACE1) or the g-secretase complex.
The g-secretase complex itself is a multimeric aspartyl protease
composed of at least four subunits: PS1 (or PS2), nicastrin,
Aph-1, and Pen-2 (De Strooper and Annaert, 2010; Goutte
et al., 2002; Hasegawa et al., 2004; Kimberly et al., 2003; Sher-
rington et al., 1995; Yu et al., 2000). Recently, some g-secre-
tase-interacting components have been identified, which
modulate g-secretase activity, including CD147 (Zhou et al.,
2005), TMP21 (Chen et al., 2006), phospholipase D1 (Cai et al.,
2006), Rer1p (Spasic et al., 2007), Arc (Wu et al., 2011), and
b-arrestin1/2 (Liu et al., 2013; Thathiah et al., 2013). However,
the molecular mechanism of g-secretase activity regulation is
still largely unknown, and more work is needed to identify novel
g-secretase binding partners and define the molecular and
cellular mechanisms involved in regulating g-secretase activity.
Sorting nexins (SNXs) belong to a large family of proteins con-
taining a conserved PX domain. Many members of this family
have been shown to regulate protein sorting in early endosomes.
Although 33 mammalian SNXs and ten yeast SNXs have been
currently identified, many of the SNX proteins remain uncharac-
terized with respect to their function (Cullen, 2008). Interestingly,
several SNXs have been found to regulate APP trafficking and
cleavage, including SNX12, SNX17, and SNX33 (Lee et al.,
2008; Scho¨bel et al., 2008; Zhao et al., 2012). SNX27 was initially
identified in rats as a product generated from alternative splicingeports 9, 1023–1033, November 6, 2014 ª2014 The Authors 1023
Figure 1. SNX27 Protein Modulates APP
Processing/Ab Generation
(A) Knockdown of SNX27 using shRNAs in human
HEK293swe cells increased secreted Ab. Ab in
the conditioned medium was precipitated and
analyzed by immunoblot analysis. Cell lysates
were prepared and 30 mg total protein per lanewas
used for immunoblot analysis, and a-tubulin was
used as a loading control.
(B) Knockdown of SNX27 using siRNA in human
HEK293swe cells increased secreted Ab. Over-
expression of a full-length SNX27, but not an
SNX27DPDZ construct, reversed RNAi-induced
Ab upregulation. Protein levels were analyzed by
immunoblot using antibodies as indicated.
In (A) and (B), data represent mean ± SEM, n = 3;
p values were calculated using a two-tailed Stu-
dent’s t test; *p < 0.05, NS, not significant.of the Mrt1 (methamphetamine responsive transcript 1) gene.
SNX27 comprises two variants, SNX27a and SNX27b. SNX27a
is expressed constitutively in the brain and testis, whereas
SNX27b is induced in the brain following methamphetamine
treatment (Kajii et al., 2003). As a PX-domain protein, SNX27, co-
localizes with EEA1 in early endosomes and transferrin receptors
in recycling endosomes (Cai et al., 2011). In addition, SNX27
exclusively contains a PDZ domain that is not found in other
PX-domain proteins. PDZ domains are protein-protein interac-
tion domains that are often found in the postsynaptic density
of neuronal excitatory synapses. Our previous studies showed
that SNX27 deficiency contributes to the synaptic and cognitive
deficits in DS patients, and overexpression of SNX27 in a Ts65Dn
DS mouse model rescues associated cognitive and synaptic im-
pairments (Wang et al., 2013b). Although the mechanism under-
lying SNX27 deficiency-induced synaptic dysfunction has been
linked to the dysregulation of glutamate receptor trafficking
(Loo et al., 2014; Wang et al., 2013b), whether SNX27 deficiency
contributes to other aspects of DS neuropathology, especially
amyloid burden, still remains unknown.
Here, we identified SNX27 as a g-secretase interaction partner
and a regulator of g-secretase activity. We demonstrated that
depletion of SNX27 results in increased g-secretase activity
and Ab production, and overexpression of the SNX27 protein de-
creases Ab generation in AD transgenic mice by inhibiting g-sec-
retase activity. The identification of SNX27’s role in modulating
g-secretase activity and Ab generation provides a molecular
mechanism for AD-like neurodegeneration in DS patients.
RESULTS
SNX27 Expression Reduces Ab Generation In Vitro
To investigate if SNX27 deficiency affects Ab generation, we
found that downregulation of SNX27 expression by short hairpin1024 Cell Reports 9, 1023–1033, November 6, 2014 ª2014 The AuthorsRNAs (shRNAs) in human embryonic
kidney 293 (HEK293) cells stably overex-
pressing human APP695 with the Swed-
ish mutations (HEK293swe) markedly
increased Ab generation (Figure 1A).Furthermore, overexpression of a full-length SNX27, but not
a PDZ-domain-deficient SNX27 (SNX27DPDZ), construct
reversed RNAi-induced Ab enhancement (Figure 1B). Since Ab
peptide is generated through a sequential cleavage of APP by
both b-secretase (BACE1) and g-secretase, we next determined
whether SNX27 decreases Ab levels by modulating BACE1 pro-
tein expression. We measured BACE1 protein levels in SNX27-
depleted cells (Figure 1A) and found no change in its protein
expression. The Ab precursor APP was also found largely un-
changed even though Ab was markedly increased by SNX27
knockdown. The unchanged amount of APP may be explained
by the fact that only a small fraction of APP is subjected to amy-
loidogenic cleavage leading to Ab generation. The potential
change in the amount of APP was harder to detect in this partic-
ular experiment, where APPwas overexpressed by an excessive
amount.
SNX27 Expression Decreases g-Secretase Activity
In Vitro and In Vivo
Ab accumulation can also be attributed to an increase in g-sec-
retase-mediated cleavage. To determine whether SNX27 affects
g-secretase activity, we first measured APP intracellular domain
(AICD) generation (a C-terminal APP g-cleavage product). We
found that SNX27 overexpression decreases AICD generation,
while knockdown of SNX27 increases AICD generation in
HEK293swe cell crude membranes (Figure 2A).
In addition to APP, the Notch receptor has been previously
described as a g-secretase substrate (Kopan and Goate,
2000). We found that Notch intracellular domain (NICD, the
g-cleavage product of Notch) was increased by knockdown of
SNX27 in NotchDE (the active form of Notch1) expressing
HeLa cells (Figure 2B). Moreover, overexpression of full-length
SNX27, but not SNX27DPDZ, reversed the NICD increase result-
ing from SNX27 knockdown (Figure 2C). Likewise, amounts of
Figure 2. SNX27 Protein Regulates g-Cleavage of APP and Notch
(A) Generation of AICD in crude membrane suspensions from HEK293swe cells transfected with SNX27-Myc/vector control or SNX27 shRNA/scrambled shRNA
vector for 48 hr.
(B) Knockdown of SNX27 using a shRNA increased g-secretase cleavage of Notch receptors. Expression level of NICD in NotchDE-expressing HeLa cells
transfected with SNX27 shRNA or scramble shRNA control vectors.
(C) siRNA-mediated knockdown of SNX27 increased NICD generation in NotchDE-expressing HeLa cells. Overexpression of a full-length SNX27, but not an
SNX27DPDZ, construct reversed RNAi-induced NICD enhancement.
(D) Expression levels of NICD in newborn Snx27+/+ and Snx27+/mouse liver lysates. Tissue lysates were prepared and 50 mg total protein per lane was used for
immunoblot analysis, and b-actin was used as a loading control.
Data represent mean ± SEM, n = 3 for (A)–(C), n = 4 mice for (D). For (A), (B), and (D), p values were calculated using a two-tailed Student’s t test. For (C), p values
were calculated using a one-way ANOVA with Tukey’s post hoc analysis. *p < 0.05; NS, not significant.NICD are higher in the liver lysates of Snx27+/ mice than in
Snx27+/+ controls (Figure 2D). These data indicate that SNX27
expression decreases Ab production through modulating/inhib-
iting g-secretase activity.
To determine whether SNX27 decreases Ab levels by modu-
lating b-secretase or g-secretase activity, we first performed a
fluorescence resonance energy transfer (FRET)-based b-secre-
tase activity assay and found that both overexpression andCell Rknockdown of SNX27 did not affect b-secretase activity (Fig-
ure 3A). However, by using a FRET-based g-secretase activity
assay, we found that overexpression of SNX27 reduces g-secre-
tase activity, whereas knockdown of SNX27 by a shRNA in-
creases g-secretase activity in HEK293T cells (Figure 3B). In
addition, g-secretase activity is markedly enhanced in the
hippocampi of Snx27+/ mice compared with Snx27+/+ controls
(Figure 3C).eports 9, 1023–1033, November 6, 2014 ª2014 The Authors 1025
Figure 3. SNX27 Expression Regulates
g-Secretase Activity In Vitro and In Vivo
(A) Effect of SNX27 modulation on b-secretase
activity. Left: HEK293swe cells were transfected
with SNX27-Myc or control vectors for 48 hr and
assayed for b-secretase activity as described in
Experimental Procedures. Right: HEK293swe
cells were transfected with SNX27 shRNA or
scramble RNA vector for 48 hr and assayed for
b-secretase activity.
(B) Effect of SNX27 modulation on g-secretase
activity. HEK293swe cells were transfected with
SNX27-Myc/control vector or SNX27 shRNA/
scrambled shRNA vectors for 48 hr and assayed
for g-secretase activity.
(C) Newborn Snx27+/+ and Snx27/ mouse brain
tissues were assayed for g-secretase activity.
For (A)–(C), data represent mean ± SEM, n = 3;
p values were calculated using a two-tailed Stu-
dent’s t test (*p < 0.05).SNX27 Modulates g-Secretase Complex Stability
through Interaction with Presenilin 1
To determine whether SNX27 regulates g-secretase activity
through physical interactions with the g-secretase complex,
we transfected glutathione S-transferase (GST)-tagged SNX27
into HEK293T cells and assayed for interactions between GST-
SNX27 and g-secretase subunits by GST pull-down assays.
We found that SNX27 can interact with PS1 N-terminal fragment
(PS1 NTF), but not with nicastrin (Figures 4A and S1A). In
HEK293T cells cotransfected with GFP-SNX27 and GST-PS1
NTF/GST-PS1 C-terminal fragment (PS1CTF), both GST-tagged
PS1 NTF and PS1 CTF coprecipitated with GFP-SNX27 (Figures
4B and S1B). Furthermore, we performed an in vitro binding
assay to strengthen our pull-down results. Using GST-PS1
NTF and CTF from HEK293T cells immobilized on glutathione
Sepharose, we assayed interactions with recombinant purified
His6-SNX27. The pull-down assays were performed in a strin-
gent detergent buffer (1%Triton X-100) that dissociates g-secre-
tase complex (Capell et al., 1998; Li et al., 2000) and weak
protein-protein interactions. Results from our in vitro binding
assays indicate that His6-SNX27 binds to both PS1 NTF and
CTF physically (Figures 4C and S1C). Moreover, we found that
both GST-full-length SNX27 and the GST-SNX27 PDZ domain
associated with PS1 NTF and PS1 CTF. However, GST-SNX27
lacking a PDZ domain (GST-SNX27DPDZ) largely failed to
interact with PS1 protein fragments (Figures 4D and S1D). In
addition, using an in silico prediction method, we found a puta-
tive PDZ binding motif in PS1 (PS1 amino acids [aa] 464–467
QFYI). However, according to previous studies, the C-terminal
residue is extracellular (Henricson et al., 2005; Laudon et al.,
2005; Spasic et al., 2006), suggesting that this residue may be1026 Cell Reports 9, 1023–1033, November 6, 2014 ª2014 The Authorsnot a bona fide PDZ binding motif. In
order to determine whether the interac-
tion between SNX27 and PS1 is a clas-
sical interaction of the PDZ domain-PDZ
binding motif, we performed an in vitro
binding assay using GST-PS1 CTF and
PS1 CTF D464–467 immobilized onglutathione Sepharose, and we found that His6-SNX27
binds to both GST-PS1 CTF and PS1 CTF without QFYI motif
(PS1 CTF D464–467) (Figure S2). This suggests that the PS1
aa464–467 QFYI motif is not required for SNX27 binding.
Furthermore, an antibody against the PS1 loop region coimmu-
noprecipitated with endogenous SNX27 in human brain lysates
(Figures 4E and S1E), confirming our pull-down results. These
results demonstrate a physical interaction between SNX27
and PS1.
SNX27 Expression Affects the Integrity of g-Secretase
Complex
As SNX27 has been found to be a crucial regulator of endocy-
tosis/recycling, we determined whether SNX27 regulates traf-
ficking of the g-secretase complex. We performed a biotinylation
assay and found that overexpression (Figure S3A) or knock-
down of SNX27 (Figure S3B) failed to affect cell-surface
amounts of PS1 NTF, PS1 CTF, nicastrin, and Pen-2. In addition,
unlike the effect on recycling of glutamate receptors that we
previously observed (Loo et al., 2014; Wang et al., 2013b),
overexpression or knockdown of SNX27 in HEK293T cells did
not affect the recycling rate of biotin-labeled PS1 (Figures S3C
and S3D).
To study the gain-of-function of SNX27 on g-secretase com-
plex stability and Ab generation, we used an adeno-associated
viral (AAV) vector encoding either enhanced GFP (eGFP) or hu-
man SNX27-IRES-eGFP cDNA to overexpress eGFP (as control)
or SNX27 in primary neurons and mouse brain. Overexpression
of human SNX27 in rat primary neurons reduced expression
amounts of g-secretase subunits, including PS1 NTF, PS1
CTF, Pen-2, and Aph-1a (Figure 5A). As expected, SNX27
Figure 4. SNX27 Interacts with the PS1 Subunit of the g-Secretase Complex
(A) Coprecipitation of the PS1 N-terminal fragment (NTF) with GST-SNX27. HEK293T cells were transfected with either GST-SNX27 or GST control vector. Cell
lysates were precipitated with glutathione Sepharose beads and immunoblotted with anti-GST, nicastrin, or PS1 NTF antibodies as indicated.
(B) Coprecipitation of SNX27 with PS1 NTF or PS1 CTF fragments. Plasmids expressing GFP-SNX27 were cotransfected with vectors expressing GST
alone, GST-NTF, or GST-CTF in HEK293T cells. Cell lysates were precipitated with glutathione Sepharose beads and immunoblotted for GFP or GST as
indicated.
(C) In vitro binding of GST-PS1 and His6-SNX27. GST-PS1 NTF and CTF recombinant proteins were purified from GST-PS1 NTF and CTF-transfected HEK293T
cells and immobilized on glutathione Sepharose, and recombinant His6-SNX27 was purified from E. coli. The pull-down assay was performed in 1%Triton X-100.
(D) The SNX27 PDZ domain is required for interaction between SNX27 and PS1. GST-SNX27, GST-SNX27 lacking the PDZ domain (SNX27DPDZ), or GST-SNX27
PDZ expressed in HEK293T cells were precipitated with glutathione Sepharose beads, and endogenous PS1 NTF and CTF was detected by immunoblot.
(E) Coimmunoprecipitation of endogenous SNX27 and g-secretase subunits in human cerebral cortical tissue. Human cerebral cortical lysate was immuno-
precipitated with antibodies against g-secretase subunits (Ru716 for nicastrin, PS1 loop for PS1 CTF) or rabbit immunoglobulin G as described in Experimental
Procedures and immunoblotted for the g-secretase subunits or SNX27 as indicated.overexpression upregulated expression of glutamate receptor
subunits GluR1 and NR1 (Figure 5A), supporting the differential
effects of SNX27 in regulating trafficking/metabolism of g-secre-
tase complex and glutamate receptors.
Similar to the result obtained from SNX27 knockdown study in
HEK293swe cells (Figure 1A), the protein amounts of g-secre-
tase subunits were unchanged in the hippocampi of Snx27/
mice compared to that in Snx27+/+ mice, although App protein
levels were slightly decreased in the hippocampi of Snx27/
mice compared to that in Snx27+/+ mice (Figure S4). This slight
reduction in App in Snx27/ mouse brain may be due to
increased cleavage by g-cleavage.
To determine whether Snx27 deletion affects integrity of the
g-secretase complex, we examined g-secretase complex levels
using native PAGE. The amounts of high-molecular-weight
g-secretase complex were more abundant in the hippocampi
of Snx27+/ mice compared to that in Snx27+/+ mice (Figure 5B).
These data may suggest that Snx27 deficiency enhances the
integrity of the g-secretase complex.Cell RSNX27 Overexpression Decreases Ab Generation
In Vivo
An SNX27 overexpression mouse model was developed in
which AAV-SNX27 was stereotactically injected into one side
of the hippocampus of the Tg2576 mouse, a well-established
model exhibiting accelerated Ab amyloidosis attributable to
expression of familial AD Swedish mutations (Hsiao et al.,
1996). As the control, AAV-eGFP was stereotactically injected
into the opposing hippocampus of the same mouse. Four
weeks after stereotactic injection of the virus, the mice were
sacrificed and the hippocampi were isolated for Ab ELISA
and immunoblot analysis. Expression of human SNX27 in the
hippocampus of Tg2576 mice (AAV-SNX27) resulted in a
decrease of both Ab40 and Ab42 amounts in the hippocampus
of Tg2576 mice compared to that in AAV-eGFP infected
Tg2576 mice (Figure 6A). In addition, overexpression of human
SNX27 in Tg2576 mouse brains by AAV infection increased pro-
tein levels of APP CTFs compared to that in AAV-eGFP infected
mice (Figure 6B). As expected, overexpression of SNX27eports 9, 1023–1033, November 6, 2014 ª2014 The Authors 1027
Figure 5. Modulation of SNX27 Expression
Affects g-Secretase Complex Stability
(A) Levels of the various g-secretase subunits (PS1
NTF, PS1 CTF, Pen-2, Aph-1a, and Nicastrin) and
glutamate receptors (GluR1 and NR1) in rat primary
neurons infected with AAV containing SNX27-IRES-
eGFP or eGFP (control) were measured by immu-
noblot. Data represent mean ± SEM, n = 3. p values
were calculated using a two-tailed Student’s t test
(*p < 0.05).
(B) Hippocampi of Snx27+/+ and Snx27+/ mice
were extracted in 1% dodecylmaltoside and pro-
cessed for blue native PAGE analysis. Immunoblot
analysis for various g-secretase subunits indicates
that Snx27 haploinsufficiency in Snx27+/ mice re-
sults in increased levels of mature g-secretase
complex compared to that in wild-type littermates.resulted in upregulation of glutamate receptor subunits GluR1
and GluR2 (Figure 6B).
Genetic Deletion of Snx27 Promotes Ab Generation and
Neuronal Loss in a Transgenic Mouse Model of AD
We crossed male Tg2576 mice with female Snx27+/ mice
and examined soluble human Ab levels in 2-month-old
Tg2576;Snx27+/+ and Tg2576;Snx27+/ mice. Both hAb40
and hAb42 amounts were higher in the hippocampi of
Tg2576;Snx27+/ mice compared to that in Tg2576;Snx27+/+
mice (Figure 6C). NeuN has been previously characterized as a
marker of mature neurons in the adult brain, and NeuN staining
is lost in degenerating neurons (Larsson et al., 2001;Wyss-Coray
et al., 2002). In the absence of the human APP transgene,
Snx27+/ mice did not show loss of NeuN staining compared
to Snx27+/+ littermates (Figure S5). However, in Tg2576;
Snx27+/mice, the dentate gyrus (DG) subregion and the cortical
region exhibit a loss of NeuN immunostaining (Figure 7A). The
numbers of NeuN-positive neurons in the CA1 and CA3 regions
showed no significant difference between Tg2576;Snx27+/+ and
Tg2576;Snx27+/ mice (Figure 7A). Taken together, our data
show that Snx27 deficiency increases Ab levels and Ab-medi-
ated neuronal loss, supporting a role of Snx27 in regulating Ab
generation.
DISCUSSION
Our study investigated a molecular mechanism for g-secretase
regulation by SNX27, a protein-trafficking regulator that has1028 Cell Reports 9, 1023–1033, November 6, 2014 ª2014 The Authorsbeen recently demonstrated to play an
important role in the pathogenesis of DS
(Loo et al., 2014; Wang et al., 2013b).
SNX27 binds to PS1 and disrupts the
g-secretase complex/activity and the
consequent cleavage of g-secretase sub-
strates, including APP and Notch. The
mechanism underlying SNX27-regulated
Ab generation is complicated, as it has
been reported that SNX27 regulates traf-
ficking of several important transmem-brane receptors, such as b2-adrenergic receptor (Lauffer et al.,
2010; Temkin et al., 2011), 5HT4a receptors (Joubert et al.,
2004), and GIRK channels (Lunn et al., 2007; Munoz and Sle-
singer, 2014). The contribution of these pathways may also
have additional effects in APP processing, as the b2-adrenergic
receptor has been reported to modulate Ab generation (Ni et al.,
2006). Moreover, it has been reported that SNX27 regulates traf-
ficking of several transmembrane proteins in association with the
retromer complex (Steinberg et al., 2013). Two components of
retromer complex, VPS26 and VPS35 (Muhammad et al., 2008;
Small et al., 2005; Wen et al., 2011), are involved in regulating
b-secretase activity and endocytic trafficking of BACE1, hence
regulating Ab generation. However, we found that SNX27 only
regulates g-secretase complex and activity without affecting
trafficking and activity of BACE1 (Figures S3A and S3B). In addi-
tion, SNX27 has been reported to regulate recycling of glutamate
receptors from early endosomes to the plasma membrane. As
the SNX27/retromer complex is essential for preventing lyso-
somal degradation and maintaining surface levels of several
transmembrane proteins (Steinberg et al., 2013; Temkin et al.,
2011), SNX27 could also function to increase g-secretase
recruitment from early endosomes to plasma membrane. How-
ever, we did not detect an SNX27-dependent change in the
rate of recycling of g-secretase subunits (Figures S3C and
S3D). Therefore, we favor a model that SNX27 may directly
interact with and thus disrupts the integrity of the g-secretase
complex in early endosomes (Figure 7B). Since previous reports
indicate that SNX27 binds the APP NPxY peptide sequence
through its FERM-like domain (Ghai et al., 2011), it will be very
Figure 6. SNX27 Expression Regulates Ab
Generation in AD Transgenic Mice
(A) Ab40 and Ab42 levels in hippocampal lysates
from 6-month-old Tg2576 mice injected with AAV-
SNX27 (left side) and AAV-eGFP (right side) were
individually determined by ELISA. Data represent
mean ±SEM, n = 3. p values were calculated using
a two-tailed Student’s t test (*p < 0.05).
(B) Immunoblot analysis of APP CTFs, GluR1, and
GluR2 levels in hippocampi of Tg2576 mice in-
jected with AAV-eGFP and AAV-SNX27. Signal
intensity of the immunoblots was normalized to
a-tubulin; n = 3. p values were calculated using a
two-tailed Student’s t test (*p < 0.05).
(C) Human Ab40 and Ab42 levels were measured
by ELISA in hippocampal lysates from 2- to
3-month-old Snx27+/+;Tg2576 and Snx27+/;
Tg2576 mice. Data represent mean ± SEM;
Snx27+/+;Tg2576, n = 4; Snx27+/;Tg2576, n = 5.
p values were calculated using a two-tailed
Student’s t test (*p < 0.05).interesting to examine the effects of SNX27 on APP trafficking in
future studies. In our previous study, we found that SNX27 is
downregulated in DS brains through a microRNA-155 (miR-
155)-C/EBPb-SNX27 pathway. miR-155 is encoded by chromo-
some 21, which is triplicated only in DS and not in AD, and we
found that the expression of SNX27 in our cohort of sporadic
AD human brains is unchanged. However, this does not discount
its importance in AD pathogenesis. There are many factors
contributing to AD pathology in DS brains, including microRNAs,
BACE1, APP, and SNX27. It is difficult to determine the relative
contribution from each factor, future research and genetic
studies may provide us with clues as to whether any SNX27 var-
iants or abnormal modifications are involved in AD pathogenesis.
SNX27 is best known for its role in trafficking synaptic recep-
tors and other transmembrane proteins. Increased SNX27
expression results in upregulation of synaptic strength by
increasing the rate of glutamate receptor recycling, which is
important in both DS and AD. The present study reports that
downregulation of SNX27 increases Ab generation. Since our
previous work observed reduced expression of SNX27 in DS
brains (Wang et al., 2013b), SNX27 depletion and consequent
upregulation of Ab generation could contribute to the amyloid
deposition associated with AD-like phenotypes in DS. Our
studies determined the association between Snx27 deletion
and Ab generation in vitro and in AD transgenic Tg2576 mice.
Notably, Ab elevation associatedwith Snx27 deficiency is partic-
ularly evident in younger mice (2–3 months of age) and became
much less evident in older mice. Mouse Ab40 levels were found
to only slightly increase but showed no statistical significance in
the hippocampi of Snx27+/mice (7 months of age) compared to
that in Snx27+/+ mice (data not shown). SNX27 deletion has been
reported to affect metabolic activities of nonneuronal cells
(Steinberg et al., 2013) that may affect Ab generation (Katsouri
et al., 2011; Wang et al., 2013a) and synaptic activity in neurons
(Wang et al., 2013b), which has also been reported to modulate
Ab generation (Cirrito et al., 2005; Kamenetz et al., 2003). Hence,
the reduced synaptic activity due to Snx27 deficiency might inCell Rturn contribute to APP cleavage leading to a reduction of Ab gen-
eration in Snx27 knockout mouse models, especially in older
ages. This may explain why Snx27 deletion does not enhance
Ab generation in 7-month-old Tg2576 mice. Additionally, the
loss of neurons resulting from Snx27 deficiency and consequent
reduction of Ab generation in aged neurons could neutralize the
effect of Snx27 deficiency-induced Ab generation in older
Tg2576 mice. Snx27 function in synaptic plasticity-dependent
cognitive function and Ab generation may suggest a funda-
mental link between cognitive decline and amyloidogenic APP
processing that is disrupted in DS/AD.EXPERIMENTAL PROCEDURES
Cells, Antibodies, and Reagents
HEK293 cells and HEK293 cells stably expressing human APP Swedish muta-
tions (HEK293Swe) were cultured in Dulbecco’s modified Eagle’s medium
(Hyclone) supplemented with 10% fetal bovine serum (Gibco) and 1% peni-
cillin/streptomycin (Gibco), in the absence and presence of 400 mg/ml G418
(Sigma), respectively.
Primary cortical neurons from embryonic day 17 (E17) rat pups were main-
tained in neurobasal medium supplemented with B27 and 0.8 mM glutamine.
Antibodies used in these experiments include NeuN (mouse monoclonal
antibody [mAb], Millipore), Nicastrin (mouse mAb, Abcam), Aph-1a (Invitro-
gen), Pen-2 (Abcam), cleaved Notch1 (Val1744, Cell Signaling), anti-Notch1
intracellular domain antibody (rabbit polyclonal antibody [pAb], Abcam),
FLAG (mAb, clone M2, Sigma), GluR1 (mAb, Chemicon), GluR2 (pAb, Milli-
pore), NR1 (mAb, BD Biosciences), a-tubulin (mAb, Sigma), b-actin (mAb,
Sigma), Myc (9E10, Santa Cruz Biotechnology), and Ab (6E10, Covance).
The rabbit polyclonal antibodies against PS1 loop (Thinakaran et al., 1996)
and SNX27 (Balana et al., 2011) were described previously. The mouse mono-
clonal antibody (clone 3D5) against BACE1 was described previously (Zhao
et al., 2007). The rabbit polyclonal antibody 369 against the APP C terminus
(Xu et al., 1997), anti-nicastrin (Ru716), and anti-PS1 NTF antibody (Ab14)
was developed in our laboratory.
Crossing Snx27+/ Mice with Tg2576 Mice
Female heterozygous Snx27 knockout (Snx27+/) mice (Cai et al., 2011; Wang
et al., 2013b) were crossed with male heterozygous Tg2576 mice harboring
Swedish familial mutations in the human APP gene (Hsiao et al., 1996) toeports 9, 1023–1033, November 6, 2014 ª2014 The Authors 1029
Figure 7. Genetic Deletion of Snx27 Pro-
motes Neuronal Loss in AD Transgenic
Mice
(A) Neuronal loss in Tg2576 mouse brain with
Snx27 haploinsufficiency. Brain sections from
6-month-old Tg2576 mice with Snx27+/ or
Snx27+/+ backgrounds were analyzed for NeuN
immunostaining. Snx27+/;Tg2576 brain sections
showed a comparatively higher level of neuronal
loss in cortical and hippocampal dentate gyrus
(DG), but not CA1 and CA3, subregions compared
to Snx27+/+;Tg2576 mice as determined by
NeuN staining. Data represent mean ± SEM,
Snx27+/+;Tg2576, n = 3; Snx27+/;Tg2576, n = 3.
p values were calculated using a two-tailed
Student’s t test (*p < 0.05). Scale bar, 100 mm.
(B) A schematic model of SNX27 in regulating
g-secretase complex formation and Ab genera-
tion. SNX27 binds to PS1 and disassociates the
g-secretase complex, whose individual compo-
nents are degraded by lysosomes and/or protea-
somes, thereby reducing APP g-cleavage. As
SNX27 is downregulated in Down syndrome
brains, reduced SNX27 levels may also contribute
to amyloid pathology in Down syndrome.generate Tg2576;Snx27+/+ and Tg2576;Snx27+/ mice. All procedures
involving animals were performed under the guidelines of Sanford-Burnham
Medical Research Institute (SBMRI) Institutional Animal Care and Use
Committee.
Constructs
The pCI-neo-SNX27-Myc plasmid and the pCI-neo control plasmids were
described previously (Rinco´n et al., 2007; Wang et al., 2013b). The pIPuro vec-
tor was generated from pCDNA3 with an IRES-puromycin resistance marker
cloned into the 30 XbaI site. FLAG was inserted into HindIII/BamHI sites
using 50-AGCTTACCATGGACTACAAAGACGATGACGATAAAGGAGGCG-30
and 50-GATCCGCCTCCTTTATCGTCATCGTCTTTGTAGTCCATGGTA-30 oli-
gos, where the full-length SNX27 and SNX27DPDZ DNA fragments were
cloned in-frame using BamHI and NotI cloning sites. His6-SNX27 construct1030 Cell Reports 9, 1023–1033, November 6, 2014 ª2014 The Authorswas generated by inserting full-length human
SNX27 into a pTrcHis A vector (Invitrogen). The
DNA fragments encoding the PS1 NTF, PS1
CTF, and PS1 CTF lacking the last four amino
acids, SNX27 and SNX27DPDZ, were inserted
into the pRK5mGST vector (Huang et al., 2013)
to generate GST-tagged constructs. Notch NDE
plasmid was previously reported (Schroeter
et al., 1998).
RNAi
Targeting sequences of shRNAs for human
SNX27 (shRNA1: CCTGAAGAGAGAGTTTGCC,
shRNA2: GGTTACATCAAAGCAGAAG) or scram-
bled shRNA were constructed into a pSuper
construct (Invitrogen) with BglII and SalI enzymatic
sites. The human SNX27 small interfering RNA
(siRNA) used was 50-CCAGAUGGAACAACG
GUUATT-30. The control siRNA was purchased
from QIAGEN.
Ab Immunoblot and ELISA Assay
HEK293swe cells in six-well plates were trans-
fected with either SNX27-myc/control vector orSNX27 shRNA/scramble RNA. To detect the total level of secreted Ab, cells
were transfected for 24–48 hr and then incubated with 1 ml Opti-MEM for
4 hr. Conditioned media was then collected and incubated with trichloroacetic
acid (1:9 v/v) overnight at 4C for protein precipitation. Precipitated proteins
were subjected to immunoblot with the anti-human Ab antibody 6E10.
Mouse hippocampi were isolated and lysed in RIPA buffer (supplemented
with Roche protease inhibitors). The levels of Ab40 and Ab42 were quantified
using ELISA kits (Invitrogen), following the manufacturer’s protocols.
Immunoblot Analysis
Treated cells or brain tissues were lysed in Nonidet P-40 lysis buffer (1%NP40
in PBS supplementedwith a protease inhibitor mixture) or 13RIPA buffer (with
a protease inhibitor mixture), respectively. Total protein concentrations in cell
lysates or brain homogenates were determined by the bicinchoninic acid
assay (BCA) method (Pierce). A total of 30–50 mg protein from cell lysates or
tissue homogenates was boiled in an SDS sample buffer prior to being sepa-
rated on Novex 4%–20% Tris-glycine protein gels (Invitrogen). Equal protein
amounts of lysate were analyzed and immunoblotted with the antibodies as
indicated. Densitometric analyses of immunoblots were performed using
NIH ImageJ software.
Blue Native PAGE
Brain tissue was homogenized in 1 3 sample buffer (1% n-dodecyl b-D-mal-
toside, Invitrogen) for 10 min on ice. Centrifuge the lysate at 20,000 3 g for
30 min at 4C. A total of 1 U/ml benzonase (endonuclease) was added, fol-
lowed by MgCl2 (2 mM) at room temperature for 20 min. The lysate was
centrifuged at 20,000 3 g for 30 min at 4C. Protein concentration was
determined by BCA. G250 (0.25%) was added, and 4%–16% native gels
(Invitrogen) were run at 150 V. After the Coomassie brilliant blue dye
front migrated about one-third the length of the gel, we replaced the dark-
blue cathode buffer with a light-blue cathode buffer. The gel was
incubated in 0.1% SDS, 192 mm glycine, 25 mm Tris, and 20% methanol
for 10 min at room temperature and then transferred onto polyvinylidene
difluoride membranes (Millipore). The blot was destained for 1 hr in distilled
water/methanol/acetic acid (60/30/10) and incubated with the indicated
antibodies.
In Vitro AICD Generation Assay
The in vitro AICD generation assay was modified from methods described
previously (Edbauer et al., 2002). Briefly, HEK293swe cells were resus-
pended (0.5 ml/6 cm dish) in ice-cold hypotonic homogenization buffer
(10 mM MOPS [pH 7.0], 10 mM KCl, without protease inhibitors) and incu-
bated on ice for 10 min. Following homogenization on ice with a VWR
1.5 ml pestle, a postnuclear supernatant was prepared by centrifugation at
1,000 3 g for 15 min at 4C. Crude membranes were isolated from the post-
nuclear supernatant by centrifugation at 13,000 3 g for 40 min at 4C. The
membranes were then resuspended (50 ml/6 cm dish) in assay buffer
(150 mM sodium citrate [pH 6.4], supplemented with the protease inhibitors),
and AICD was generated by incubation of samples at 37C for 2 hr in a
volume of 25 ml/assay. After termination of the assay reactions on ice, sam-
ples were separated into pellet and supernatant fractions by ultracentrifuga-
tion for 1 hr at 100,000 3 g at 4C. The supernatant and pellet fractions were
prepared in a SDS loading buffer and then separated by SDS-PAGE on
4%–20% Tris-glycine gels (Invitrogen) and analyzed by immunoblot with
anti-APP C-terminal antibody 369.
GST Pull-Down Assay
PS1 NTF and PS1 CTF cDNAs or full-length SNX27 and SNX27 deletion con-
structs were cloned into the pRK5mGST mammalian expression vector. GST-
PS1 NTF/CTF constructs were cotransfected with GFP-SNX27 into HEK293T
cells, lysates were generated in cell lysis buffer (20mM Tris-HCl [pH 7.5],
0.15 M NaCl, 5% glycerol, 10 mM MgCl2, and 1% NP40, with protease inhib-
itors), and GST proteins were precipitated for 2 hr at 4C with glutathione
Sepharose. GST-SNX27 and SNX27 deletion constructs were transfected
into HEK293T cells, and lysates were probed with glutathione Sepharose. Pre-
cipitates were washed three times in lysis buffer and boiled in SDS-PAGE
loading buffer. Eluates and lysate inputs were immunoblotted for either GFP
or endogenous PS1/nicatrin subunits.
In Vitro Protein-Protein Binding Assay
HEK293T cells were seeded at 70% confluency onto 10 cm dishes coated
with poly-D lysine and transfected with pRK5mGST-NTF, CTF, and CTF
constructs lacking the last four amino acids. Cells were lysed 16 hr
following transfection in 1% Triton X-100 buffer, and GST proteins were
loaded onto glutathione Sepharose with gentle agitation at 4C for 1–2 hr.
Beads were washed with 1% Triton X-100 and incubated with 3 mg of
recombinant His6-SNX27 protein in standard buffer for 2 hr with gentle agita-
tion at 4C. Beads were washed (generally 3 3 800 ml for 20 min at 4C with
gentle agitation), and bound complexes were boiled and analyzed by immu-
noblot analysis. A total of 1 mg of recombinant His6-SNX27 was loaded as
input.Cell RCoimmunoprecipitation
Human brain tissue was lysed in NP40 buffer (1% Nonidet P-40 in PBS, sup-
plemented with Roche protease inhibitors). Lysates were immunoprecipitated
using rabbit immunoglobulin G and indicated antibodies as well as Trueblot IP
beads (eBioscience), followed by immunoblot with indicated antibodies.
b-Secretase Activity Assay
A FRET-based assay commercial kit was used to assess b-secretase activity
(Sigma-Aldrich) according to the manufacturer’s instructions.
g-Secretase Fluorogenic Substrate Assay
Weperformed the assay as described previously (Farmery et al., 2003; Ni et al.,
2006). After centrifugation of cell lysates or tissue homogenates at 13,0003 g
for 15 min, pellets were resuspended and then incubated at 37C for 2 hr in
50 ml of assay buffer (50 mM Tris-HCl [pH 6.8], 2 mM EDTA, 0.25% CHAPSO)
containing 8 mM fluorogenic substrates (Calbiochem). Fluorescence was
measured using a SpectraMax M5 spectrometer (Molecular Devices) with
the excitation wavelength set at 355 nm and the emission wavelength set
at 440 nm.
Immunohistochemistry
Tg2576;Snx27+/+ and Tg2576;Snx27+/ mice were anesthetized and fixed by
cardiac perfusion with 4% paraformaldehyde (PFA). Whole brains were
excised and postfixed in 4% PFA overnight. Tissue blocks were embedded
in paraffin, and 5 mm sections were cut. For immunohistochemistry, deparaffi-
nized sections were incubated in citrate buffer (pH 7.0), treated with 3% H2O2
followed by 3% normal horse serum, and incubated overnight at 4C with pri-
mary antibodies against NeuN (1:100), followed by diaminobenzidine (DAB)
staining using a DAB peroxidase substrate kit (Vector Laboratories). Immuno-
stained sections were examined and fluorescence images collected using a
Zeiss fluorescence microscope with AxioVision software.
Stereotactic Injection of Adeno-Associated Virus
Stereotactic injection was performed as described previously (Wang et al.,
2013b). Recombinant human SNX27 and eGFP adeno-associated virus
(2 ml, titer 3 3 1012) were stereotactically injected into the hippocampus of
Tg2576 mice at the following coordinates: anterior posterior, 1.8; medial
lateral, ±1.8; dorsal ventral, 1.8. To confirm region-specific overexpression
of SNX27 in mouse brains, 4 weeks after injection, mice were anesthetized
and sacrificed, whereupon brain tissues were rapidly removed. Hippocampal
lysates were prepared by homogenizing tissue in RIPA buffer in the absence of
protease inhibitors for Ab ELISA or immunoblot analysis.
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